2-[(2-amino-2-oxoethyl)-[3-[[4-(4,5-difluoro-2-methylsulfanylphenyl)phenoxy]methyl]benzoyl]amino]acetic acid
C25H22F2N2O5S — CID 118872754
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(2-amino-2-oxoethyl)-[3-[[4-(4,5-difluoro-2-methylsulfanylphenyl)phenoxy]methyl]benzoyl]amino]acetic acid
2-[(2-amino-2-oxoethyl)-[3-[[4-(4,5-difluoro-2-methylsulfanylphenyl)phenoxy]methyl]benzoyl]amino]acetic acid (PubChem CID 118872754) has the molecular formula C25H22F2N2O5S and a molecular weight of 500.52 g/mol. Its IUPAC name is 2-[(2-amino-2-oxoethyl)-[3-[[4-(4,5-difluoro-2-methylsulfanylphenyl)phenoxy]methyl]benzoyl]amino]acetic acid.
Molecular Properties
| Compound Name | 2-[(2-amino-2-oxoethyl)-[3-[[4-(4,5-difluoro-2-methylsulfanylphenyl)phenoxy]methyl]benzoyl]amino]acetic acid |
|---|---|
| PubChem CID | 118872754 |
| Molecular Formula | C25H22F2N2O5S |
| Molecular Weight | 500.52 g/mol |
| Exact Mass | 500.12 |
| IUPAC Name | 2-[(2-amino-2-oxoethyl)-[3-[[4-(4,5-difluoro-2-methylsulfanylphenyl)phenoxy]methyl]benzoyl]amino]acetic acid |
| SMILES | CSc1cc(F)c(F)cc1-c1ccc(OCc2cccc(C(=O)N(CC(N)=O)CC(=O)O)c2)cc1 |
| InChI | InChI=1S/C25H22F2N2O5S/c1-35-22-11-21(27)20(26)10-19(22)16-5-7-18(8-6-16)34-14-15-3-2-4-17(9-15)25(33)29(12-23(28)30)13-24(31)32/h2-11H,12-14H2,1H3,(H2,28,30)(H,31,32) |
| InChIKey | OOKBLKLACBSVEV-UHFFFAOYSA-N |
| XLogP | 3.94 |
| TPSA | 109.93 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.52 |
| LogP ≤ 5 | 3.94 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118872754 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.